Molecular Imaging and Quantitation of EphA2 Expression in Xenograft Models with Zr-89-DS-8895a
Ingrid JG Burvenich, Sagun Parakh, Hui K Gan, Fook-Thean Lee, Nancy Guo, Angela Rigopoulos, Sze-Ting Lee, Sylvia Gong, Graeme J O'Keefe, Henri Tochon-Danguy, Masakatsu Kotsuma, Jun Hasegawa, Giorgio Senaldi, Andrew M Scott
Journal of Nuclear Medicine | SOC NUCLEAR MEDICINE INC | Published : 2016
The costs of publication of this article were defrayed in part by the payment of page charges. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 USC section 1734. This work was supported by funding from Daiichi-Sankyo Co., Ltd., by the Operational Infrastructure Support program of the Victorian State Government, and by the Solid Target Laboratory, an ANSTO-Austin-LICR Partnership. We acknowledge the Australian Cancer Research Foundation for providing funds to purchase the small-animal PET/MR and SPECT/CT imaging equipment. Masakatsu Kotsuma, Jun Hasegawa, and Giorgio Senaldi are employees of Daiichi-Sankyo Co., Ltd. No other potential conflict of interest relevant to this article was reported.